biguanides has been researched along with Argentaffinoma in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herrera-Martínez, AD | 1 |
| Pedraza-Arevalo, S | 1 |
| L-López, F | 1 |
| Gahete, MD | 1 |
| Gálvez-Moreno, MA | 1 |
| Castaño, JP | 1 |
| Luque, RM | 1 |
1 other study available for biguanides and Argentaffinoma
| Article | Year |
|---|---|
Type 2 Diabetes in Neuroendocrine Tumors: Are Biguanides and Statins Part of the Solution?
Topics: Adult; Aged; Apoptosis; Biguanides; Carcinoid Tumor; Cell Line, Tumor; Cell Movement; Cell Prolifera | 2019 |